BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aparicio T, Zaanan A, Mary F, Afchain P, Manfredi S, Evans TRJ. Small Bowel Adenocarcinoma. Gastroenterology Clinics of North America 2016;45:447-57. [DOI: 10.1016/j.gtc.2016.04.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Dias E, Mascarenhas Saraiva M, Moreira F, Cardoso H, Macedo G. Small Bowel Adenocarcinoma in a Patient with Crohn’s Disease: The Role of Balloon-Assisted Enteroscopy. GE Port J Gastroenterol. [DOI: 10.1159/000520906] [Reference Citation Analysis]
2 Washington MK, Goldberg RM, Chang GJ, Limburg P, Lam AK, Salto-Tellez M, Arends MJ, Nagtegaal ID, Klimstra DS, Rugge M, Schirmacher P, Lazar AJ, Odze RD, Carneiro F, Fukayama M, Cree IA; WHO Classification of Tumours Editorial Board. Diagnosis of digestive system tumours. Int J Cancer 2021;148:1040-50. [PMID: 32674220 DOI: 10.1002/ijc.33210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Kim SW, Kim HC, Oh J, Won KY, Park SJ, Yang DM. Tumors of the jejunum and ileum: a pattern-based imaging approach on CT. Abdom Radiol 2019;44:2337-45. [DOI: 10.1007/s00261-019-01978-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Kim JS, Park SH, Hansel S, Fletcher JG. Imaging and Screening of Cancer of the Small Bowel. Radiologic Clinics of North America 2017;55:1273-91. [DOI: 10.1016/j.rcl.2017.06.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
5 Cavalla C, Oppliger F, Schiappacasse G, Valderrama R, Castiblanco A, Margarit S. Multiple synchronous adenocarcinomas of the small bowel in a young patient: A case report. Int J Surg Case Rep 2018;42:250-3. [PMID: 29324371 DOI: 10.1016/j.ijscr.2017.12.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Singh H, Krishnamurthy G, Kumar H, Mandavdhare H, Sharma V, Yadav TD. Surgical Management of Jejunal Tumors: Experience from Tertiary Care Centre. J Gastrointest Cancer 2020;51:901-7. [PMID: 31705396 DOI: 10.1007/s12029-019-00327-5] [Reference Citation Analysis]
7 Song JS, Yi JM, Cho H, Choi CH, Park Y, Chung EJ, Song J, Chung J, Hong S. Dual loss of USP10 and p14ARF protein expression is associated with poor prognosis in patients with small intestinal adenocarcinoma. Tumour Biol 2018;40:101042831880867. [DOI: 10.1177/1010428318808678] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
8 Sánchez A, Bujanda L, Cuatrecasas M, Bofill A, Alvarez-urturi C, Hernandez G, Aguilera L, Carballal S, Llach J, Herrera-pariente C, Iglesias M, Rivero-sánchez L, Jung G, Moreno L, Ocaña T, Bayarri C, Pellise M, Castells A, Castellví-bel S, Balaguer F, Moreira L. Identification of Lynch Syndrome Carriers among Patients with Small Bowel Adenocarcinoma. Cancers 2021;13:6378. [DOI: 10.3390/cancers13246378] [Reference Citation Analysis]
9 Wang N, Yang J, Lyu J, Liu Q, He H, Liu J, Li L, Ren X, Li Z. A convenient clinical nomogram for predicting the cancer-specific survival of individual patients with small-intestine adenocarcinoma. BMC Cancer 2020;20:505. [PMID: 32487033 DOI: 10.1186/s12885-020-06971-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Li Q, Chen T, Cui H, Xiao X, Chen C, Shen Z, Ji F, Yin L. Misdiagnosis of multiple synchronous small bowel adenocarcinomas as intestinal tuberculosis: a case report. BMC Gastroenterol 2020;20:112. [PMID: 32299377 DOI: 10.1186/s12876-020-01271-6] [Reference Citation Analysis]
11 Hafer A. What is causing this patient's abdominal pain? JAAPA 2018;31:53-5. [PMID: 30153207 DOI: 10.1097/01.JAA.0000544306.38577.5f] [Reference Citation Analysis]
12 Vergara JP, Sacdalan DBL, Amurao-amante M, Sacdalan DL. Bevacizumab in metastatic small-bowel adenocarcinoma: A systematic review and meta-analysis. Rare Tumors 2019;11:203636131882541. [DOI: 10.1177/2036361318825413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 Verde F, Fishman EK. Calcified pancreatic and peripancreatic neoplasms: spectrum of pathologies. Abdom Radiol 2017;42:2686-97. [DOI: 10.1007/s00261-017-1182-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
14 Abudalou M, Al Sbihi AF, Perepletchikov A, Stallwood C. Small Intestinal Adenocarcinoma in a Patient With Celiac Disease. Cureus 2021;13:e13039. [PMID: 33665060 DOI: 10.7759/cureus.13039] [Reference Citation Analysis]
15 Li N, Shen W, Deng W, Yang H, Ma Y, Bie L, Wei C, Luo S. Clinical features and the efficacy of adjuvant chemotherapy in resectable small bowel adenocarcinoma: a single-center, long-term analysis. Ann Transl Med 2020;8:949. [PMID: 32953749 DOI: 10.21037/atm-20-1503] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Sacdalan DB, Mendoza MJ, Vergara JP, Catedral LI, Ting FI, Leones LM, Berba CM, Sacdalan DL. Beyond bevacizumab: a review of targeted agents in metastatic small bowel adenocarcinoma. Med Oncol 2020;37:106. [PMID: 33135102 DOI: 10.1007/s12032-020-01432-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Zhou YW, Xia RL, Chen YY, Ma XL, Liu JY. Clinical features, treatment, and prognosis of different histological types of primary small bowel adenocarcinoma: A propensity score matching analysis based on the SEER database. Eur J Surg Oncol 2021;47:2108-18. [PMID: 33849741 DOI: 10.1016/j.ejso.2021.03.260] [Reference Citation Analysis]
18 Kirkegård J, Farkas DK, Jørgensen JOL, Cronin-Fenton D. Hyper- and hypothyroidism and gastrointestinal cancer risk: a Danish nationwide cohort study. Endocr Connect 2018:/journals/ec/aop/ec-18-0258. [PMID: 30352404 DOI: 10.1530/EC-18-0258] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Iijima K, Oozeki M, Ikeda K, Honda H, Ishibashi H, Yamaoka M, Fujieda S, Saitoh H, Goto M, Araki M, Amagai K. A case of small bowel adenocarcinoma wherein nivolumab conferred temporary benefit in disease control. Clin J Gastroenterol 2020;13:372-6. [PMID: 31701367 DOI: 10.1007/s12328-019-01064-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 González I, Goyal B, Xia MD, Pai RK, Ma C. DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma. Human Pathology 2019;85:18-26. [DOI: 10.1016/j.humpath.2018.10.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
21 Wang Z, Li W, Wei Y, An L, Su S, Xi C, Wang K, Hong D, Shi Y. A HER2-mutant patient with late-stage duodenal adenocarcinoma benefited from anti-HER2 therapy and PD-1 inhibition: a case report. J Gastrointest Oncol 2021;12:1939-43. [PMID: 34532140 DOI: 10.21037/jgo-21-311] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Yang QY, Tang CT, Huang YF, Shao DT, Shu X. Development and validation of a nomogram for primary duodenal carcinoma: a multicenter, population-based study. Future Oncol 2022. [PMID: 35114801 DOI: 10.2217/fon-2021-0622] [Reference Citation Analysis]
23 Chen EY, Vaccaro GM. Small Bowel Adenocarcinoma. Clin Colon Rectal Surg 2018;31:267-77. [PMID: 30186048 DOI: 10.1055/s-0038-1660482] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Burasakarn P, Higuchi R, Nunobe S, Kanaji S, Eguchi H, Okada KI, Fujii T, Nagakawa Y, Kanetaka K, Yamashita H, Yamada S, Kuroda S, Aoyama T, Akahori T, Nakagawa K, Yamamoto M, Yamaue H, Sho M, Kodera Y; Japan Duodenal Cancer Guideline Committee. Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis. Int J Clin Oncol 2021;26:450-60. [PMID: 33386555 DOI: 10.1007/s10147-020-01840-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Suerink M, Kilinç G, Terlouw D, Hristova H, Sensuk L, van Egmond D, Farina Sarasqueta A, Langers AMJ, van Wezel T, Morreau H, Nielsen M; PALGA-group collaborators. Prevalence of mismatch repair deficiency and Lynch syndrome in a cohort of unselected small bowel adenocarcinomas. J Clin Pathol 2020:jclinpath-2020-207040. [PMID: 33046565 DOI: 10.1136/jclinpath-2020-207040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Oweira H, Abdel-Rahman O, Mehrabi A, Reissfelder C. Assessment of the external validity of the AJCC 8th staging system for small intestinal adenocarcinoma: a time to reconsider the role of tumor location? J Gastrointest Oncol 2019;10:421-8. [PMID: 31183191 DOI: 10.21037/jgo.2019.01.15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Kim SH, Kim JW. Small Bowel Malignancies in Patients Undergoing Capsule Endoscopy for Iron Deficiency Anemia. Diagnostics 2022;12:91. [DOI: 10.3390/diagnostics12010091] [Reference Citation Analysis]
28 Singh K, Singh A, Philpott J, Liska D, Lai K. Occult Adenocarcinoma Arising in Crohn’s-Related Strictures: A Case Series. Crohn's & Colitis 360 2019;1:otz038. [DOI: 10.1093/crocol/otz038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]